Objectives: Anorectal cytology (ARC) is a widely used screening tool for anal cancer in human immunodeficiency virus (HIV)-infected men who have sex with men (MSM). Its diagnostic accuracy needs to be improved, especially for high-grade squamous intraepithelial lesions (HSILs).
Human immunodeficiency virus (HIV)-infected men who have sex with men (MSM) are highly susceptible to human papillomavirus (HPV) infection of the anal canal owing to sexual practices and immunocompromised status.
1,2 HPV 16 and 18 are the most common oncogenic viral types. 3 The virus can transform anal squamous epithelia to anal intraepithelial neoplasia (AIN), graded as 1, 2, and 3. AIN 2 and 3 are well-defined cancer precursors that can progress to invasive cancer if left untreated. 4, 5 In 2012, the Lower Anogenital Squamous Terminology (LAST) project recommended new terminology for reporting HPV-related lesions: low-grade squamous intraepithelial lesion (LSIL) and highgrade squamous intraepithelial lesion (HSIL). 6 This twotiered classification reflects our current understanding of HPV carcinogenesis: LSILs (synonymous with AIN 1) represent transient infection, whereas HSILs (AIN 2 and 3) represent persistent infection with a high risk of progression to cancer. Anal cancer screening in HIV-infected MSM aims to detect the cancer precursor (HSIL) before invasion occurs. 7, 8 Currently, anal screening programs are still in a nascent stage and are not yet widely available to patients who are at increased risk of anal cancer. Cytology has had great success in cervical cancer prevention and has now been adopted as a screening tool for anal cancer in high-risk populations. 9, 10 However, the performance of anorectal cytology (ARC) has been inconsistent, as demonstrated by its wide range of sensitivity (69%-93%) and relatively low specificity (32%-59%).
11-13
A survey by the College of American Pathologists in 2010 revealed that ARC diagnostic accuracy for HSILs was only 58.4% for pathologists and even lower for cytotechnologists (53.1%). 14 Such modest concordance has changed little over the past six annual surveys. Multiple studies have demonstrated that HSILs and even invasive carcinoma are frequently underdiagnosed on cytology, underscoring ARC's deficiency as a primary screening test. [15] [16] [17] As a result, the current practice is to refer patients with any abnormal cytology result other than benign for high-resolution anoscopy (HRA) and biopsy. 18 Several known factors contribute to ARC's suboptimal performance, including sample adequacy, quality of prepared slides, and most important, diagnostic challenges. 19, 20 When encountering ARC samples, most pathologists apply cervical diagnostic criteria owing to the similar morphologic features between the cervix and anus. Indeed, metaplastic-type HSILs are the most common presentation of high-grade lesions in both. The challenge lies in the lesser-known HSIL variants such as keratinized type that are uncommon in cervical lesions but fairly prevalent in anal ones. Only a small number of studies have focused on the morphologic features and diagnostic limitations specific to anal specimens. [21] [22] [23] Our practice serves a large HIV-infected MSM population. We routinely perform anal cytology and HRAguided biopsy during the same encounter, allowing us to correlate histologic and cytologic diagnoses. In the current study, anal HSIL biopsy specimens paired with cytology samples from 100 HIV-infected MSM were retrospectively analyzed with the aim of determining strategies to improve cytologic diagnostic accuracy for high-grade lesions. Four parameters were analyzed: (1) solitary vs multifocal lesions, (2) cytology sample cellularity, (3) presence or absence of transformation zone, and (4) the morphologic variants of HSIL (metaplastic vs keratinized types).
Materials and Methods
After institutional review board approval from Mount Sinai Health System was obtained, we searched our clinicopathologic database from January 2014 to December 2015 using keywords AIN 2, AIN 3, and AIN 2/3. Only patients meeting the following criteria were included in the study: (1) men self-reporting as MSM, (2) HIV seropositive, (3) a minimum of four HRA-guided biopsy specimens taken from four different quadrants of the anal canal, and (4) a cytology sample collected during the same visit. Patients whose cytology samples were reported as unsatisfactory (fewer than two nucleated squamous cells/high-power field, NSCs/hpf) were excluded. 24 The following demographic characteristics were extracted from the electronic medical record: age, CD4þ T-cell count, HIV-1 viral load, antiretroviral therapy, and history of anogenital condyloma. Anal cytology collection, HRA, and biopsy were performed during the same office visit by a single provider (M.M.G.). Briefly, a moistened, nonlubricated cytobrush was inserted 5 to 6 cm into the anal canal to collect cells from the anal verge to above the squamocolumnar junction. The cells were preserved in liquid-based cytology medium for ThinPrep (Cytyc, Boxborough, MA) and stained with the Papanicolaou stain. All slides were manually screened by cytotechnologists and reported by cytopathologists from the Division of Cytology, Mount Sinai Hospital. ARC results were reported using the 2001 Bethesda System criteria and categories: negative; atypical squamous cells of undetermined significance (ASCUS); LSIL; atypical squamous cells, cannot exclude HSIL (ASC-H); and HSIL. 24 Oncogenic HPV subtype analysis was performed from liquid cytology fluid regardless of anal cytology result using the Roche Cobas HPV kit (Roche Diagnostics, Indianapolis, IN) that is able to detect 14 types of high-risk HPV (16, 18 , and other types, including 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68). HRA was performed according to previously described techniques. 25 After treatment with 3% acetic acid and Lugol's iodine, the squamocolumnar junction, distal anal canal, and the anal margin were visualized under magnification to look for abnormal vascular patterns and other potential signs of HSILs or cancer, including ulceration, mass effect, and friability. Areas suspicious for HSILs or cancer were biopsied. Two authors (Y.L. and T.K.) independently reviewed and classified all biopsy samples using a combination of LAST terminology (LSIL and HSIL) and AIN terminology (AIN 1, 2, and 3). Occasionally, AIN 2/3 was designated. We recorded the number of biopsy specimens positive for high-grade lesions as well as their types (metaplastic or keratinized). Without knowledge of the original cytologic diagnoses, two authors (Y.L. and X.W.) reviewed all cytology slides, primarily searching for HSIL cells. Suspected HSIL cells were confirmed upon consensus review and further classified as metaplastic vs keratinized type. Metaplastic HSIL cells Image 1A and Image 1B are defined as dysplastic squamous cells with scant basophilic cytoplasm, markedly hyperchromatic nucleus with coarse chromatin, irregular contours, and high nuclear-tocytoplasmic ratio. Keratinized HSIL cells Image 1C and Image 1D show similar nuclear features as the metaplastic type, except their cytoplasm appears to be orangeophilic, consistent with keratinization. Both types of HSIL cells can present as small (corresponding to AIN 3) or intermediate (AIN 2) in size and may occur singly or in clusters. In addition, the following parameters were recorded for every cytology sample: (1) cellularity ("low" is defined as 2-10 NSCs/hpf; "high" is defined as >10 NSCs/hpf), (2) presence or absence of columnar cells, and (3) the predominant type of HSIL cells on a given slide.
All statistical analyses were performed in STATA 13 (StataCorp, College Station, TX). Fisher exact or v 2 tests were used to determine the significance of associations between parameters. A P value less than .05 was considered statistically significant.
Results

Patient Characteristics
One hundred patients who met the aforementioned criteria were included. All patients were prescribed antiretroviral therapy at the time of visit. Table 1 illustrates patient demographics. Median age was 42 years (range, 23-65 years), and median CD4þ T-cell count was 703 cells/mL (range, 155-1,874 cells/mL). CD4þ T-cell count was below 400 in 15 patients and above 400 in 85. HIV-1 viral load was less than 20 copies/mL in 77 patients and above 
Biopsy Slide Review
A total of 453 HRA-guided biopsies were taken from the 100 patients (range, four to seven per patient). Of 453 biopsy specimens, 263 (58%) were reported as HSILs, including AIN 3 (n ¼ 24, 9%), AIN 2 (n ¼ 207, 79%), and AIN 2/3 (n ¼ 32, 12%). Respectively, HRA-guided biopsy identified one, two, three, or four or more sites of high-grade lesions in 22, 29, 22, and 27 patients. On histologic evaluation of biopsy samples, 53 patients had predominately metaplastictype AIN 2/3 Image 2A and Image 2B , 30 had predominately keratinized AIN 2/3 Image 2C and Image 2D , and the remaining 17 had both types.
Cytology Slide Review
Cytology samples were originally reported as negative (n ¼ 2), ASCUS (n ¼ 42), LSIL (n ¼ 32), ASC-H (n ¼ 9), and HSIL (n ¼ 15). Upon retrospective review, definitive HSIL cells were present in 58 samples (aka positive samples) and absent in the remaining 42 (aka negative samples). As shown in Table 2 , among 32 samples with low cellularity, 12 (38%) were positive while 20 (62%) were negative samples. Among 68 samples with high cellularity, 46 (68%) were positive while 22 (32%) were negative. Comparing low-vs high-cellularity samples, a significantly higher percentage of the latter contained HSIL cells (P < .05). Columnar cells (ie, those representing the transformation zone) were absent in seven, all of which (100%) were negative samples. Among 93 samples containing columnar cells, 58 (62%) were positive and 35 (38%) were negative for HSIL cells.
Among patients with one, two, three, or four or more sites of biopsy-proven HSIL, positive cytology samples were eight (36%) of 22, 14 (48%) of 29, 15 (68%) of 22, and 21 (78%) of 27, respectively. Negative cytology samples for each group were 14 (64%) of 22, 15 (52%) of 29, seven (32%) of 22, and six (22%) of 27. Comparing cytology samples obtained from patients with multifocal vs solitary lesions, a significantly higher percentage of the former contained HSIL cells (P < .05).
Cytology slides were divided into three groups based on original diagnosis. As shown in Table 3 , cytology samples originally reported as HSILs (n ¼ 15) included metaplastic-type HSILs (n ¼ 6, 40%), keratinized-type HSILs (n ¼ 1, 7%), and cases with both metaplastic and keratinized types (n ¼ 8, 53%). Samples originally reported as ASC-H (n ¼ 9) included metaplastic-type HSILs (n ¼ 7, 78%) and cases with both (n ¼ 2, 22%). Among samples originally reported as LSILs or less (n ¼ 76), HSIL cells were absent in 42 cases. Notably, the remaining 34 cases included metaplastic type (n ¼ 13, 38%), a significant increase in keratinized type (n ¼ 15, 44%; P < .05), and both (n ¼ 6, 18%).
Discussion
For the past decade, specialized anal dysplasia clinics, including ours, have been incorporating ARC as a primary screening tool for anal cancer in high-risk populations. Despite significant progress, ARC's diagnostic accuracy and reproducibility still need to be refined, especially for the diagnosis of HSILs. Using a cohort of 100 HIVþ MSM, we set out to determine ways to improve cytologic performance with respect to HSILs, focusing on sample collection and pathologic diagnosis.
ARC samples are more challenging to collect than cervical ones since the anal canal is larger and covered with a corrugated mucosa that is difficult to survey thoroughly. 26 The challenge is further compounded because the procedure is performed without direct visualization of the anal canal. Despite these limitations, the results of our review indicate that ARC successfully detected HSILs in 58% of cases. For patients with multiple lesions (four or more), the detection rate was as high as 78%. For those with less extensive disease (one or two lesions), ARC was able to collect sufficient HSIL cells for diagnosis in 43%. Our results demonstrate that ARC is more prone to detect multifocal lesions than localized ones. Ideally, HRA-guided biopsy should be performed alongside cytology to increase overall screening sensitivity. Notably, we observed a significant difference between samples of high vs low cellularity. The current adequacy criterion for ARC samples is a minimum of two NSCs/hpf. We found that samples high in cellularity-namely, 10þ NSCs/hpf-were strongly concordant with biopsy (68%). Conversely, samples considered "adequate" by current criteria and yet of low cellularity (2-10 NSCs/hpf) had weak concordance (38%). Another important adequacy criterion is the presence of columnar cells, representing a satisfactory survey of the transformation zone (t-zone) or squamocolumnar junction. 28, 29 Darragh et al 30 reported that when samples contain a t-zone, AIN is five times more likely to be detected. This observation held true in our study for HSILs. Most of our samples (93%) included t-zones, whereas the only seven samples lacking such components failed to collect HSIL cells. Keratinized HSILs appear to be more common in the anus than cervix. On biopsy, 30 of our 100 patients had pure keratinized HSILs, while an additional 17 displayed a combination of keratinized and metaplastic types. Recognizing keratinized HSILs is not particularly challenging in histopathology but remains problematic in cytology specimens. Upon review, we found that 21 (62%) of 34 of cytology samples originally reported as LSILs or less contained the rare keratinized-type HSILs. Keratinized HSIL cells tend to be sparse and isolated and are therefore frequently overlooked, leading to cytologic underdiagnoses. Faquin et al 31 reported similar limitations in cervical cytology: diagnostic accuracy for keratinized HSILs was significantly lower than for nonkeratinized ones (60% vs 95%). They concluded that the difficulty in grading is due to the overlapping of cells into thick plaques, hindering assessment of the nuclear/cytoplasmic ratio. Friedlander et al 32 noted comparable diagnostic ambiguity regarding ARC samples and further warned of the critical error in overdiagnosing atypical parakeratotic cells as squamous cell carcinoma. In summary, our results demonstrate that among HIVinfected MSM, ARC's overall detection rate for anal HSILs is 58%, ranging widely from 36% for solitary lesions to 78% for multifocal lesions. Samples with combined high cellularity and transformation zone show high sensitivity. During cytologic screening, keratinized-type HSILs are frequently overlooked, resulting in underdiagnoses. Pathologists need to become more proficient in the interpretation of keratinized lesions as these are common presentations in anal samples. Our findings should improve the ARC detection rate for anal HSILs, helping to implement ARC as the primary screening tool for anal cancer prevention. 
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